Aprea Therapeutics (public company)
See something wrong or missing? Let us know
Offices:Stockholm
Industry:BiotechHealth services
Business model:B2B
Aprea Therapeutics is a clinical-stage biotechnology company developing novel anticancer therapies targeting the p53 tumor suppressor protein
Investors:
we tracked 3 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 113.6M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Aprea Therapeutics
Name | Criteria | |
---|---|---|
![]() |
Achilles Therapeutics
53%
|
|
![]() |
Atai Life Sciences
53%
|
|
![]() |
Biofidelity
53%
|
|
![]() |
BoneSupport
53%
|
|
![]() |
CatalYm
53%
|
|
![]() |
Galecto Biotech
53%
|
|
![]() |
InnovaFeed SAS
53%
|
|
![]() |
LabGenius
53%
|
|
![]() |
MaaT Pharma
53%
|
|
![]() |
MedTrace
53%
|
|